Our results not only provide a basis for the concept that high expression of AIB1, as detected by IHC, may be a promising predictor of aggressive cervical cancer patients with poor response to CRT, but also suggest that it might serve as a new potential target to overcome the resistance of radiotherapy in cervical cancer. Here, NCOA3 is linked to cervical cancer.